Hyperbaric oxygen therapy (HBOT) can be used as an adjunctive therapy for managing patients with diabetic foot ulcers (DFUs). Guidelines and a pathway were developed to support the referral of patients with DFUs for HBOT from a specialist multidisciplinary clinic. 

​Guidelines offer support to health professionals and patients when making decisions about care or treatment. Clinical pathways are a tool used more easily in practice when decisions and care must happen swiftly. They allow consistency of treatment. The guidelines described were written using national and international recommendations and consensus. They will be reviewed at a later date, yet to be decided due to coronavirus (COVID-19), to ensure successful implementation and that they meet local and national requirements.